CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total revenue	$ 90,059	$ 85,518
Operating expenses:
Research and development	5,838	49
General and administrative	6,492	5,986
Total operating expenses	12,330	6,035
Income from operations	77,729	79,483
Interest and dividend income	322	30
Other expense, net	(250)	(433)
Interest expense	(3,010)	(4,694)
Loss on extinguishment of debt	(20,662)	0
Changes in fair values of equity and long-term investments, net	(9,411)	55,045
Income before income taxes	44,718	129,431
Income tax expense, net	6,860	19,736
Net income	37,858	109,695
Net income attributable to noncontrolling interest	22,085	15,572
Net income attributable to Innoviva stockholders	$ 15,773	$ 94,123
Basic net income per share attributable to Innoviva stockholders	$ 0.23	$ 0.93
Diluted net income per share attributable to Innoviva stockholders	$ 0.20	$ 0.84
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	69,544	101,365
Shares used to compute diluted net income per share	93,730	113,624